Login / Signup

NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma.

Xin YuLijun XuYongqiang ZhouXiaorong ZhouLei YangYan Zhou
Published in: Journal of inflammation research (2023)
In conclusion, NUP62CL could be an effective prognostic and immunological biomarker for OSCC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes